Teva Pharmaceutical Industries Ltd.
↗Tel Aviv, Israel
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, headquartered in Israel. It is the world's largest generic drug manufacturer, providing thousands of products that reach approximately 200 million patients daily. The company's portfolio includes a vast range of generic medicines across nearly every therapeutic area, alongside a growing franchise of innovative specialty products and biosimilars.
Under its 'Pivot to Growth' strategy launched in 2023, Teva is shifting its focus toward high-value innovative medicines and biosimilars to offset the impact of generic competition. Key innovative assets include Austedo for Huntington's disease, Ajovy for migraine prevention, and Uzedy for schizophrenia. The company also maintains a robust pipeline of 18 biosimilar assets and is actively reducing its debt and streamlining its global manufacturing footprint.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic and Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:10000+
Revenue:$17.3B (2025)
Founded:1901
Ownership:public
Status:operating
FUNDING
Stage:Pre-IPO
Total Raised:$2.4B
Investors:Blackstone Life Sciences, Royalty Pharma
STOCK
Exchange:NYSE
Ticker:TEVA
Market Cap:$39.02B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Austedo, Ajovy, Uzedy)
Modalities:Small molecule, mAb, Biosimilars, Injectables
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 18 | Phase 4: 5
FDA Approvals:500
EMA Approvals:400
CORPORATE STRUCTURE
Subsidiaries:Teva Gyógyszergyár Zrt. (Hungary), Teva Pharmaceuticals USA, Inc., Mepha (Switzerland)
Key Partnerships:Sanofi (Duvakitug collaboration), Blackstone Life Sciences ($400M funding for Duvakitug), Alvotech (Biosimilar commercialization)
COMPETITION
Position:Leader
Competitors:Sandoz, Viatris, Dr. Reddy's Laboratories, Hikma Pharmaceuticals
LEADERSHIP
Key Executives:
Richard Francis - President and CEO
Eli Kalif - EVP and CFO
Dr. Eric A. Hughes - EVP, Global R&D and CMO
Scientific Founders:Günther Friedländer, Chaim Salomon, Moshe Levin, Yitschak Elstein
Board Members:Sol J. Barer (Chairman), Richard Francis, Rosemary A. Crane
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Teva Pharmaceutical Industries Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.